Global Small Molecule Drug CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Small Molecule Drug CDMO market size was valued at USD 28650 million in 2022 and is forecast to a readjusted size of USD 42080 million by 2029 with a CAGR of 5.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
This report is a detailed and comprehensive analysis for global Small Molecule Drug CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Small Molecule Drug CDMO market size and forecasts, in consumption value ($ Million), 2018-2029
Global Small Molecule Drug CDMO market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Small Molecule Drug CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Small Molecule Drug CDMO market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Small Molecule Drug CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Small Molecule Drug CDMO market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics and Fareva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Small Molecule Drug CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Small Molecule Drug CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Small Molecule Drug CDMO, with revenue, gross margin and global market share of Small Molecule Drug CDMO from 2018 to 2023.
Chapter 3, the Small Molecule Drug CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Small Molecule Drug CDMO market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Small Molecule Drug CDMO.
Chapter 13, to describe Small Molecule Drug CDMO research findings and conclusion.
A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
This report is a detailed and comprehensive analysis for global Small Molecule Drug CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Small Molecule Drug CDMO market size and forecasts, in consumption value ($ Million), 2018-2029
Global Small Molecule Drug CDMO market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Small Molecule Drug CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Small Molecule Drug CDMO market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Small Molecule Drug CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Small Molecule Drug CDMO market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics and Fareva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Small Molecule Drug CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- FDF CDMO
- Packaging CDMO
- Clinical CDMO
- Pharmaceutical Company
- Biotechnology Company
- Other
- Lonza
- Catalent
- Thermo Fisher Scientific
- Samsung Biologics
- Fareva
- WuXi AppTech
- WuXi Biologics
- Siegfried
- FUJIFILM Diosynth Biotechnologies
- Asymchem
- Pfizer CentreOne
- Delpharm
- Recipharm
- AGC Pharma Chemicals
- Boehringer Ingelheim
- Vetter
- Curia
- Aenova
- Porton
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Small Molecule Drug CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Small Molecule Drug CDMO, with revenue, gross margin and global market share of Small Molecule Drug CDMO from 2018 to 2023.
Chapter 3, the Small Molecule Drug CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Small Molecule Drug CDMO market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Small Molecule Drug CDMO.
Chapter 13, to describe Small Molecule Drug CDMO research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Small Molecule Drug CDMO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Small Molecule Drug CDMO by Type
1.3.1 Overview: Global Small Molecule Drug CDMO Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Small Molecule Drug CDMO Consumption Value Market Share by Type in 2022
1.3.3 FDF CDMO
1.3.4 Packaging CDMO
1.3.5 Clinical CDMO
1.4 Global Small Molecule Drug CDMO Market by Application
1.4.1 Overview: Global Small Molecule Drug CDMO Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Company
1.4.3 Biotechnology Company
1.4.4 Other
1.5 Global Small Molecule Drug CDMO Market Size & Forecast
1.6 Global Small Molecule Drug CDMO Market Size and Forecast by Region
1.6.1 Global Small Molecule Drug CDMO Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Small Molecule Drug CDMO Market Size by Region, (2018-2029)
1.6.3 North America Small Molecule Drug CDMO Market Size and Prospect (2018-2029)
1.6.4 Europe Small Molecule Drug CDMO Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Small Molecule Drug CDMO Market Size and Prospect (2018-2029)
1.6.6 South America Small Molecule Drug CDMO Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Small Molecule Drug CDMO Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Small Molecule Drug CDMO Product and Solutions
2.1.4 Lonza Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Lonza Recent Developments and Future Plans
2.2 Catalent
2.2.1 Catalent Details
2.2.2 Catalent Major Business
2.2.3 Catalent Small Molecule Drug CDMO Product and Solutions
2.2.4 Catalent Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Catalent Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Small Molecule Drug CDMO Product and Solutions
2.3.4 Thermo Fisher Scientific Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 Samsung Biologics
2.4.1 Samsung Biologics Details
2.4.2 Samsung Biologics Major Business
2.4.3 Samsung Biologics Small Molecule Drug CDMO Product and Solutions
2.4.4 Samsung Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Samsung Biologics Recent Developments and Future Plans
2.5 Fareva
2.5.1 Fareva Details
2.5.2 Fareva Major Business
2.5.3 Fareva Small Molecule Drug CDMO Product and Solutions
2.5.4 Fareva Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Fareva Recent Developments and Future Plans
2.6 WuXi AppTech
2.6.1 WuXi AppTech Details
2.6.2 WuXi AppTech Major Business
2.6.3 WuXi AppTech Small Molecule Drug CDMO Product and Solutions
2.6.4 WuXi AppTech Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 WuXi AppTech Recent Developments and Future Plans
2.7 WuXi Biologics
2.7.1 WuXi Biologics Details
2.7.2 WuXi Biologics Major Business
2.7.3 WuXi Biologics Small Molecule Drug CDMO Product and Solutions
2.7.4 WuXi Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 WuXi Biologics Recent Developments and Future Plans
2.8 Siegfried
2.8.1 Siegfried Details
2.8.2 Siegfried Major Business
2.8.3 Siegfried Small Molecule Drug CDMO Product and Solutions
2.8.4 Siegfried Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Siegfried Recent Developments and Future Plans
2.9 FUJIFILM Diosynth Biotechnologies
2.9.1 FUJIFILM Diosynth Biotechnologies Details
2.9.2 FUJIFILM Diosynth Biotechnologies Major Business
2.9.3 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product and Solutions
2.9.4 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.10 Asymchem
2.10.1 Asymchem Details
2.10.2 Asymchem Major Business
2.10.3 Asymchem Small Molecule Drug CDMO Product and Solutions
2.10.4 Asymchem Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Asymchem Recent Developments and Future Plans
2.11 Pfizer CentreOne
2.11.1 Pfizer CentreOne Details
2.11.2 Pfizer CentreOne Major Business
2.11.3 Pfizer CentreOne Small Molecule Drug CDMO Product and Solutions
2.11.4 Pfizer CentreOne Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Pfizer CentreOne Recent Developments and Future Plans
2.12 Delpharm
2.12.1 Delpharm Details
2.12.2 Delpharm Major Business
2.12.3 Delpharm Small Molecule Drug CDMO Product and Solutions
2.12.4 Delpharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Delpharm Recent Developments and Future Plans
2.13 Recipharm
2.13.1 Recipharm Details
2.13.2 Recipharm Major Business
2.13.3 Recipharm Small Molecule Drug CDMO Product and Solutions
2.13.4 Recipharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Recipharm Recent Developments and Future Plans
2.14 AGC Pharma Chemicals
2.14.1 AGC Pharma Chemicals Details
2.14.2 AGC Pharma Chemicals Major Business
2.14.3 AGC Pharma Chemicals Small Molecule Drug CDMO Product and Solutions
2.14.4 AGC Pharma Chemicals Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 AGC Pharma Chemicals Recent Developments and Future Plans
2.15 Boehringer Ingelheim
2.15.1 Boehringer Ingelheim Details
2.15.2 Boehringer Ingelheim Major Business
2.15.3 Boehringer Ingelheim Small Molecule Drug CDMO Product and Solutions
2.15.4 Boehringer Ingelheim Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Boehringer Ingelheim Recent Developments and Future Plans
2.16 Vetter
2.16.1 Vetter Details
2.16.2 Vetter Major Business
2.16.3 Vetter Small Molecule Drug CDMO Product and Solutions
2.16.4 Vetter Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Vetter Recent Developments and Future Plans
2.17 Curia
2.17.1 Curia Details
2.17.2 Curia Major Business
2.17.3 Curia Small Molecule Drug CDMO Product and Solutions
2.17.4 Curia Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Curia Recent Developments and Future Plans
2.18 Aenova
2.18.1 Aenova Details
2.18.2 Aenova Major Business
2.18.3 Aenova Small Molecule Drug CDMO Product and Solutions
2.18.4 Aenova Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Aenova Recent Developments and Future Plans
2.19 Porton
2.19.1 Porton Details
2.19.2 Porton Major Business
2.19.3 Porton Small Molecule Drug CDMO Product and Solutions
2.19.4 Porton Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Porton Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Small Molecule Drug CDMO Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Small Molecule Drug CDMO by Company Revenue
3.2.2 Top 3 Small Molecule Drug CDMO Players Market Share in 2022
3.2.3 Top 6 Small Molecule Drug CDMO Players Market Share in 2022
3.3 Small Molecule Drug CDMO Market: Overall Company Footprint Analysis
3.3.1 Small Molecule Drug CDMO Market: Region Footprint
3.3.2 Small Molecule Drug CDMO Market: Company Product Type Footprint
3.3.3 Small Molecule Drug CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Small Molecule Drug CDMO Consumption Value and Market Share by Type (2018-2023)
4.2 Global Small Molecule Drug CDMO Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Small Molecule Drug CDMO Consumption Value Market Share by Application (2018-2023)
5.2 Global Small Molecule Drug CDMO Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Small Molecule Drug CDMO Consumption Value by Type (2018-2029)
6.2 North America Small Molecule Drug CDMO Consumption Value by Application (2018-2029)
6.3 North America Small Molecule Drug CDMO Market Size by Country
6.3.1 North America Small Molecule Drug CDMO Consumption Value by Country (2018-2029)
6.3.2 United States Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
6.3.3 Canada Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
6.3.4 Mexico Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Small Molecule Drug CDMO Consumption Value by Type (2018-2029)
7.2 Europe Small Molecule Drug CDMO Consumption Value by Application (2018-2029)
7.3 Europe Small Molecule Drug CDMO Market Size by Country
7.3.1 Europe Small Molecule Drug CDMO Consumption Value by Country (2018-2029)
7.3.2 Germany Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
7.3.3 France Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
7.3.5 Russia Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
7.3.6 Italy Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Small Molecule Drug CDMO Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Small Molecule Drug CDMO Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Small Molecule Drug CDMO Market Size by Region
8.3.1 Asia-Pacific Small Molecule Drug CDMO Consumption Value by Region (2018-2029)
8.3.2 China Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
8.3.3 Japan Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
8.3.4 South Korea Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
8.3.5 India Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
8.3.7 Australia Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Small Molecule Drug CDMO Consumption Value by Type (2018-2029)
9.2 South America Small Molecule Drug CDMO Consumption Value by Application (2018-2029)
9.3 South America Small Molecule Drug CDMO Market Size by Country
9.3.1 South America Small Molecule Drug CDMO Consumption Value by Country (2018-2029)
9.3.2 Brazil Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
9.3.3 Argentina Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Small Molecule Drug CDMO Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Small Molecule Drug CDMO Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Small Molecule Drug CDMO Market Size by Country
10.3.1 Middle East & Africa Small Molecule Drug CDMO Consumption Value by Country (2018-2029)
10.3.2 Turkey Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
10.3.4 UAE Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Small Molecule Drug CDMO Market Drivers
11.2 Small Molecule Drug CDMO Market Restraints
11.3 Small Molecule Drug CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Small Molecule Drug CDMO Industry Chain
12.2 Small Molecule Drug CDMO Upstream Analysis
12.3 Small Molecule Drug CDMO Midstream Analysis
12.4 Small Molecule Drug CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Small Molecule Drug CDMO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Small Molecule Drug CDMO by Type
1.3.1 Overview: Global Small Molecule Drug CDMO Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Small Molecule Drug CDMO Consumption Value Market Share by Type in 2022
1.3.3 FDF CDMO
1.3.4 Packaging CDMO
1.3.5 Clinical CDMO
1.4 Global Small Molecule Drug CDMO Market by Application
1.4.1 Overview: Global Small Molecule Drug CDMO Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Company
1.4.3 Biotechnology Company
1.4.4 Other
1.5 Global Small Molecule Drug CDMO Market Size & Forecast
1.6 Global Small Molecule Drug CDMO Market Size and Forecast by Region
1.6.1 Global Small Molecule Drug CDMO Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Small Molecule Drug CDMO Market Size by Region, (2018-2029)
1.6.3 North America Small Molecule Drug CDMO Market Size and Prospect (2018-2029)
1.6.4 Europe Small Molecule Drug CDMO Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Small Molecule Drug CDMO Market Size and Prospect (2018-2029)
1.6.6 South America Small Molecule Drug CDMO Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Small Molecule Drug CDMO Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Small Molecule Drug CDMO Product and Solutions
2.1.4 Lonza Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Lonza Recent Developments and Future Plans
2.2 Catalent
2.2.1 Catalent Details
2.2.2 Catalent Major Business
2.2.3 Catalent Small Molecule Drug CDMO Product and Solutions
2.2.4 Catalent Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Catalent Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Small Molecule Drug CDMO Product and Solutions
2.3.4 Thermo Fisher Scientific Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 Samsung Biologics
2.4.1 Samsung Biologics Details
2.4.2 Samsung Biologics Major Business
2.4.3 Samsung Biologics Small Molecule Drug CDMO Product and Solutions
2.4.4 Samsung Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Samsung Biologics Recent Developments and Future Plans
2.5 Fareva
2.5.1 Fareva Details
2.5.2 Fareva Major Business
2.5.3 Fareva Small Molecule Drug CDMO Product and Solutions
2.5.4 Fareva Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Fareva Recent Developments and Future Plans
2.6 WuXi AppTech
2.6.1 WuXi AppTech Details
2.6.2 WuXi AppTech Major Business
2.6.3 WuXi AppTech Small Molecule Drug CDMO Product and Solutions
2.6.4 WuXi AppTech Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 WuXi AppTech Recent Developments and Future Plans
2.7 WuXi Biologics
2.7.1 WuXi Biologics Details
2.7.2 WuXi Biologics Major Business
2.7.3 WuXi Biologics Small Molecule Drug CDMO Product and Solutions
2.7.4 WuXi Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 WuXi Biologics Recent Developments and Future Plans
2.8 Siegfried
2.8.1 Siegfried Details
2.8.2 Siegfried Major Business
2.8.3 Siegfried Small Molecule Drug CDMO Product and Solutions
2.8.4 Siegfried Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Siegfried Recent Developments and Future Plans
2.9 FUJIFILM Diosynth Biotechnologies
2.9.1 FUJIFILM Diosynth Biotechnologies Details
2.9.2 FUJIFILM Diosynth Biotechnologies Major Business
2.9.3 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product and Solutions
2.9.4 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.10 Asymchem
2.10.1 Asymchem Details
2.10.2 Asymchem Major Business
2.10.3 Asymchem Small Molecule Drug CDMO Product and Solutions
2.10.4 Asymchem Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Asymchem Recent Developments and Future Plans
2.11 Pfizer CentreOne
2.11.1 Pfizer CentreOne Details
2.11.2 Pfizer CentreOne Major Business
2.11.3 Pfizer CentreOne Small Molecule Drug CDMO Product and Solutions
2.11.4 Pfizer CentreOne Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Pfizer CentreOne Recent Developments and Future Plans
2.12 Delpharm
2.12.1 Delpharm Details
2.12.2 Delpharm Major Business
2.12.3 Delpharm Small Molecule Drug CDMO Product and Solutions
2.12.4 Delpharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Delpharm Recent Developments and Future Plans
2.13 Recipharm
2.13.1 Recipharm Details
2.13.2 Recipharm Major Business
2.13.3 Recipharm Small Molecule Drug CDMO Product and Solutions
2.13.4 Recipharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Recipharm Recent Developments and Future Plans
2.14 AGC Pharma Chemicals
2.14.1 AGC Pharma Chemicals Details
2.14.2 AGC Pharma Chemicals Major Business
2.14.3 AGC Pharma Chemicals Small Molecule Drug CDMO Product and Solutions
2.14.4 AGC Pharma Chemicals Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 AGC Pharma Chemicals Recent Developments and Future Plans
2.15 Boehringer Ingelheim
2.15.1 Boehringer Ingelheim Details
2.15.2 Boehringer Ingelheim Major Business
2.15.3 Boehringer Ingelheim Small Molecule Drug CDMO Product and Solutions
2.15.4 Boehringer Ingelheim Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Boehringer Ingelheim Recent Developments and Future Plans
2.16 Vetter
2.16.1 Vetter Details
2.16.2 Vetter Major Business
2.16.3 Vetter Small Molecule Drug CDMO Product and Solutions
2.16.4 Vetter Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Vetter Recent Developments and Future Plans
2.17 Curia
2.17.1 Curia Details
2.17.2 Curia Major Business
2.17.3 Curia Small Molecule Drug CDMO Product and Solutions
2.17.4 Curia Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Curia Recent Developments and Future Plans
2.18 Aenova
2.18.1 Aenova Details
2.18.2 Aenova Major Business
2.18.3 Aenova Small Molecule Drug CDMO Product and Solutions
2.18.4 Aenova Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Aenova Recent Developments and Future Plans
2.19 Porton
2.19.1 Porton Details
2.19.2 Porton Major Business
2.19.3 Porton Small Molecule Drug CDMO Product and Solutions
2.19.4 Porton Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Porton Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Small Molecule Drug CDMO Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Small Molecule Drug CDMO by Company Revenue
3.2.2 Top 3 Small Molecule Drug CDMO Players Market Share in 2022
3.2.3 Top 6 Small Molecule Drug CDMO Players Market Share in 2022
3.3 Small Molecule Drug CDMO Market: Overall Company Footprint Analysis
3.3.1 Small Molecule Drug CDMO Market: Region Footprint
3.3.2 Small Molecule Drug CDMO Market: Company Product Type Footprint
3.3.3 Small Molecule Drug CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Small Molecule Drug CDMO Consumption Value and Market Share by Type (2018-2023)
4.2 Global Small Molecule Drug CDMO Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Small Molecule Drug CDMO Consumption Value Market Share by Application (2018-2023)
5.2 Global Small Molecule Drug CDMO Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Small Molecule Drug CDMO Consumption Value by Type (2018-2029)
6.2 North America Small Molecule Drug CDMO Consumption Value by Application (2018-2029)
6.3 North America Small Molecule Drug CDMO Market Size by Country
6.3.1 North America Small Molecule Drug CDMO Consumption Value by Country (2018-2029)
6.3.2 United States Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
6.3.3 Canada Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
6.3.4 Mexico Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Small Molecule Drug CDMO Consumption Value by Type (2018-2029)
7.2 Europe Small Molecule Drug CDMO Consumption Value by Application (2018-2029)
7.3 Europe Small Molecule Drug CDMO Market Size by Country
7.3.1 Europe Small Molecule Drug CDMO Consumption Value by Country (2018-2029)
7.3.2 Germany Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
7.3.3 France Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
7.3.5 Russia Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
7.3.6 Italy Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Small Molecule Drug CDMO Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Small Molecule Drug CDMO Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Small Molecule Drug CDMO Market Size by Region
8.3.1 Asia-Pacific Small Molecule Drug CDMO Consumption Value by Region (2018-2029)
8.3.2 China Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
8.3.3 Japan Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
8.3.4 South Korea Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
8.3.5 India Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
8.3.7 Australia Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Small Molecule Drug CDMO Consumption Value by Type (2018-2029)
9.2 South America Small Molecule Drug CDMO Consumption Value by Application (2018-2029)
9.3 South America Small Molecule Drug CDMO Market Size by Country
9.3.1 South America Small Molecule Drug CDMO Consumption Value by Country (2018-2029)
9.3.2 Brazil Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
9.3.3 Argentina Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Small Molecule Drug CDMO Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Small Molecule Drug CDMO Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Small Molecule Drug CDMO Market Size by Country
10.3.1 Middle East & Africa Small Molecule Drug CDMO Consumption Value by Country (2018-2029)
10.3.2 Turkey Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
10.3.4 UAE Small Molecule Drug CDMO Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Small Molecule Drug CDMO Market Drivers
11.2 Small Molecule Drug CDMO Market Restraints
11.3 Small Molecule Drug CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Small Molecule Drug CDMO Industry Chain
12.2 Small Molecule Drug CDMO Upstream Analysis
12.3 Small Molecule Drug CDMO Midstream Analysis
12.4 Small Molecule Drug CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Small Molecule Drug CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Small Molecule Drug CDMO Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Small Molecule Drug CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Small Molecule Drug CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Lonza Company Information, Head Office, and Major Competitors
Table 6. Lonza Major Business
Table 7. Lonza Small Molecule Drug CDMO Product and Solutions
Table 8. Lonza Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Lonza Recent Developments and Future Plans
Table 10. Catalent Company Information, Head Office, and Major Competitors
Table 11. Catalent Major Business
Table 12. Catalent Small Molecule Drug CDMO Product and Solutions
Table 13. Catalent Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Catalent Recent Developments and Future Plans
Table 15. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 16. Thermo Fisher Scientific Major Business
Table 17. Thermo Fisher Scientific Small Molecule Drug CDMO Product and Solutions
Table 18. Thermo Fisher Scientific Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Thermo Fisher Scientific Recent Developments and Future Plans
Table 20. Samsung Biologics Company Information, Head Office, and Major Competitors
Table 21. Samsung Biologics Major Business
Table 22. Samsung Biologics Small Molecule Drug CDMO Product and Solutions
Table 23. Samsung Biologics Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Samsung Biologics Recent Developments and Future Plans
Table 25. Fareva Company Information, Head Office, and Major Competitors
Table 26. Fareva Major Business
Table 27. Fareva Small Molecule Drug CDMO Product and Solutions
Table 28. Fareva Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Fareva Recent Developments and Future Plans
Table 30. WuXi AppTech Company Information, Head Office, and Major Competitors
Table 31. WuXi AppTech Major Business
Table 32. WuXi AppTech Small Molecule Drug CDMO Product and Solutions
Table 33. WuXi AppTech Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. WuXi AppTech Recent Developments and Future Plans
Table 35. WuXi Biologics Company Information, Head Office, and Major Competitors
Table 36. WuXi Biologics Major Business
Table 37. WuXi Biologics Small Molecule Drug CDMO Product and Solutions
Table 38. WuXi Biologics Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. WuXi Biologics Recent Developments and Future Plans
Table 40. Siegfried Company Information, Head Office, and Major Competitors
Table 41. Siegfried Major Business
Table 42. Siegfried Small Molecule Drug CDMO Product and Solutions
Table 43. Siegfried Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Siegfried Recent Developments and Future Plans
Table 45. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 46. FUJIFILM Diosynth Biotechnologies Major Business
Table 47. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product and Solutions
Table 48. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 50. Asymchem Company Information, Head Office, and Major Competitors
Table 51. Asymchem Major Business
Table 52. Asymchem Small Molecule Drug CDMO Product and Solutions
Table 53. Asymchem Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Asymchem Recent Developments and Future Plans
Table 55. Pfizer CentreOne Company Information, Head Office, and Major Competitors
Table 56. Pfizer CentreOne Major Business
Table 57. Pfizer CentreOne Small Molecule Drug CDMO Product and Solutions
Table 58. Pfizer CentreOne Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Pfizer CentreOne Recent Developments and Future Plans
Table 60. Delpharm Company Information, Head Office, and Major Competitors
Table 61. Delpharm Major Business
Table 62. Delpharm Small Molecule Drug CDMO Product and Solutions
Table 63. Delpharm Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Delpharm Recent Developments and Future Plans
Table 65. Recipharm Company Information, Head Office, and Major Competitors
Table 66. Recipharm Major Business
Table 67. Recipharm Small Molecule Drug CDMO Product and Solutions
Table 68. Recipharm Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Recipharm Recent Developments and Future Plans
Table 70. AGC Pharma Chemicals Company Information, Head Office, and Major Competitors
Table 71. AGC Pharma Chemicals Major Business
Table 72. AGC Pharma Chemicals Small Molecule Drug CDMO Product and Solutions
Table 73. AGC Pharma Chemicals Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. AGC Pharma Chemicals Recent Developments and Future Plans
Table 75. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 76. Boehringer Ingelheim Major Business
Table 77. Boehringer Ingelheim Small Molecule Drug CDMO Product and Solutions
Table 78. Boehringer Ingelheim Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Boehringer Ingelheim Recent Developments and Future Plans
Table 80. Vetter Company Information, Head Office, and Major Competitors
Table 81. Vetter Major Business
Table 82. Vetter Small Molecule Drug CDMO Product and Solutions
Table 83. Vetter Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Vetter Recent Developments and Future Plans
Table 85. Curia Company Information, Head Office, and Major Competitors
Table 86. Curia Major Business
Table 87. Curia Small Molecule Drug CDMO Product and Solutions
Table 88. Curia Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Curia Recent Developments and Future Plans
Table 90. Aenova Company Information, Head Office, and Major Competitors
Table 91. Aenova Major Business
Table 92. Aenova Small Molecule Drug CDMO Product and Solutions
Table 93. Aenova Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Aenova Recent Developments and Future Plans
Table 95. Porton Company Information, Head Office, and Major Competitors
Table 96. Porton Major Business
Table 97. Porton Small Molecule Drug CDMO Product and Solutions
Table 98. Porton Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Porton Recent Developments and Future Plans
Table 100. Global Small Molecule Drug CDMO Revenue (USD Million) by Players (2018-2023)
Table 101. Global Small Molecule Drug CDMO Revenue Share by Players (2018-2023)
Table 102. Breakdown of Small Molecule Drug CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Small Molecule Drug CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 104. Head Office of Key Small Molecule Drug CDMO Players
Table 105. Small Molecule Drug CDMO Market: Company Product Type Footprint
Table 106. Small Molecule Drug CDMO Market: Company Product Application Footprint
Table 107. Small Molecule Drug CDMO New Market Entrants and Barriers to Market Entry
Table 108. Small Molecule Drug CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Small Molecule Drug CDMO Consumption Value (USD Million) by Type (2018-2023)
Table 110. Global Small Molecule Drug CDMO Consumption Value Share by Type (2018-2023)
Table 111. Global Small Molecule Drug CDMO Consumption Value Forecast by Type (2024-2029)
Table 112. Global Small Molecule Drug CDMO Consumption Value by Application (2018-2023)
Table 113. Global Small Molecule Drug CDMO Consumption Value Forecast by Application (2024-2029)
Table 114. North America Small Molecule Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 115. North America Small Molecule Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 116. North America Small Molecule Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 117. North America Small Molecule Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 118. North America Small Molecule Drug CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 119. North America Small Molecule Drug CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 120. Europe Small Molecule Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Europe Small Molecule Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Europe Small Molecule Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 123. Europe Small Molecule Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 124. Europe Small Molecule Drug CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Small Molecule Drug CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Small Molecule Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 127. Asia-Pacific Small Molecule Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 128. Asia-Pacific Small Molecule Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 129. Asia-Pacific Small Molecule Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 130. Asia-Pacific Small Molecule Drug CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 131. Asia-Pacific Small Molecule Drug CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 132. South America Small Molecule Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 133. South America Small Molecule Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 134. South America Small Molecule Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 135. South America Small Molecule Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 136. South America Small Molecule Drug CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 137. South America Small Molecule Drug CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Middle East & Africa Small Molecule Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 139. Middle East & Africa Small Molecule Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 140. Middle East & Africa Small Molecule Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 141. Middle East & Africa Small Molecule Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 142. Middle East & Africa Small Molecule Drug CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 143. Middle East & Africa Small Molecule Drug CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 144. Small Molecule Drug CDMO Raw Material
Table 145. Key Suppliers of Small Molecule Drug CDMO Raw Materials
Table 1. Global Small Molecule Drug CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Small Molecule Drug CDMO Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Small Molecule Drug CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Small Molecule Drug CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Lonza Company Information, Head Office, and Major Competitors
Table 6. Lonza Major Business
Table 7. Lonza Small Molecule Drug CDMO Product and Solutions
Table 8. Lonza Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Lonza Recent Developments and Future Plans
Table 10. Catalent Company Information, Head Office, and Major Competitors
Table 11. Catalent Major Business
Table 12. Catalent Small Molecule Drug CDMO Product and Solutions
Table 13. Catalent Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Catalent Recent Developments and Future Plans
Table 15. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 16. Thermo Fisher Scientific Major Business
Table 17. Thermo Fisher Scientific Small Molecule Drug CDMO Product and Solutions
Table 18. Thermo Fisher Scientific Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Thermo Fisher Scientific Recent Developments and Future Plans
Table 20. Samsung Biologics Company Information, Head Office, and Major Competitors
Table 21. Samsung Biologics Major Business
Table 22. Samsung Biologics Small Molecule Drug CDMO Product and Solutions
Table 23. Samsung Biologics Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Samsung Biologics Recent Developments and Future Plans
Table 25. Fareva Company Information, Head Office, and Major Competitors
Table 26. Fareva Major Business
Table 27. Fareva Small Molecule Drug CDMO Product and Solutions
Table 28. Fareva Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Fareva Recent Developments and Future Plans
Table 30. WuXi AppTech Company Information, Head Office, and Major Competitors
Table 31. WuXi AppTech Major Business
Table 32. WuXi AppTech Small Molecule Drug CDMO Product and Solutions
Table 33. WuXi AppTech Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. WuXi AppTech Recent Developments and Future Plans
Table 35. WuXi Biologics Company Information, Head Office, and Major Competitors
Table 36. WuXi Biologics Major Business
Table 37. WuXi Biologics Small Molecule Drug CDMO Product and Solutions
Table 38. WuXi Biologics Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. WuXi Biologics Recent Developments and Future Plans
Table 40. Siegfried Company Information, Head Office, and Major Competitors
Table 41. Siegfried Major Business
Table 42. Siegfried Small Molecule Drug CDMO Product and Solutions
Table 43. Siegfried Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Siegfried Recent Developments and Future Plans
Table 45. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 46. FUJIFILM Diosynth Biotechnologies Major Business
Table 47. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product and Solutions
Table 48. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 50. Asymchem Company Information, Head Office, and Major Competitors
Table 51. Asymchem Major Business
Table 52. Asymchem Small Molecule Drug CDMO Product and Solutions
Table 53. Asymchem Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Asymchem Recent Developments and Future Plans
Table 55. Pfizer CentreOne Company Information, Head Office, and Major Competitors
Table 56. Pfizer CentreOne Major Business
Table 57. Pfizer CentreOne Small Molecule Drug CDMO Product and Solutions
Table 58. Pfizer CentreOne Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Pfizer CentreOne Recent Developments and Future Plans
Table 60. Delpharm Company Information, Head Office, and Major Competitors
Table 61. Delpharm Major Business
Table 62. Delpharm Small Molecule Drug CDMO Product and Solutions
Table 63. Delpharm Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Delpharm Recent Developments and Future Plans
Table 65. Recipharm Company Information, Head Office, and Major Competitors
Table 66. Recipharm Major Business
Table 67. Recipharm Small Molecule Drug CDMO Product and Solutions
Table 68. Recipharm Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Recipharm Recent Developments and Future Plans
Table 70. AGC Pharma Chemicals Company Information, Head Office, and Major Competitors
Table 71. AGC Pharma Chemicals Major Business
Table 72. AGC Pharma Chemicals Small Molecule Drug CDMO Product and Solutions
Table 73. AGC Pharma Chemicals Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. AGC Pharma Chemicals Recent Developments and Future Plans
Table 75. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 76. Boehringer Ingelheim Major Business
Table 77. Boehringer Ingelheim Small Molecule Drug CDMO Product and Solutions
Table 78. Boehringer Ingelheim Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Boehringer Ingelheim Recent Developments and Future Plans
Table 80. Vetter Company Information, Head Office, and Major Competitors
Table 81. Vetter Major Business
Table 82. Vetter Small Molecule Drug CDMO Product and Solutions
Table 83. Vetter Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Vetter Recent Developments and Future Plans
Table 85. Curia Company Information, Head Office, and Major Competitors
Table 86. Curia Major Business
Table 87. Curia Small Molecule Drug CDMO Product and Solutions
Table 88. Curia Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Curia Recent Developments and Future Plans
Table 90. Aenova Company Information, Head Office, and Major Competitors
Table 91. Aenova Major Business
Table 92. Aenova Small Molecule Drug CDMO Product and Solutions
Table 93. Aenova Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Aenova Recent Developments and Future Plans
Table 95. Porton Company Information, Head Office, and Major Competitors
Table 96. Porton Major Business
Table 97. Porton Small Molecule Drug CDMO Product and Solutions
Table 98. Porton Small Molecule Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Porton Recent Developments and Future Plans
Table 100. Global Small Molecule Drug CDMO Revenue (USD Million) by Players (2018-2023)
Table 101. Global Small Molecule Drug CDMO Revenue Share by Players (2018-2023)
Table 102. Breakdown of Small Molecule Drug CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Small Molecule Drug CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 104. Head Office of Key Small Molecule Drug CDMO Players
Table 105. Small Molecule Drug CDMO Market: Company Product Type Footprint
Table 106. Small Molecule Drug CDMO Market: Company Product Application Footprint
Table 107. Small Molecule Drug CDMO New Market Entrants and Barriers to Market Entry
Table 108. Small Molecule Drug CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Small Molecule Drug CDMO Consumption Value (USD Million) by Type (2018-2023)
Table 110. Global Small Molecule Drug CDMO Consumption Value Share by Type (2018-2023)
Table 111. Global Small Molecule Drug CDMO Consumption Value Forecast by Type (2024-2029)
Table 112. Global Small Molecule Drug CDMO Consumption Value by Application (2018-2023)
Table 113. Global Small Molecule Drug CDMO Consumption Value Forecast by Application (2024-2029)
Table 114. North America Small Molecule Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 115. North America Small Molecule Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 116. North America Small Molecule Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 117. North America Small Molecule Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 118. North America Small Molecule Drug CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 119. North America Small Molecule Drug CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 120. Europe Small Molecule Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Europe Small Molecule Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Europe Small Molecule Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 123. Europe Small Molecule Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 124. Europe Small Molecule Drug CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Small Molecule Drug CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Small Molecule Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 127. Asia-Pacific Small Molecule Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 128. Asia-Pacific Small Molecule Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 129. Asia-Pacific Small Molecule Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 130. Asia-Pacific Small Molecule Drug CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 131. Asia-Pacific Small Molecule Drug CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 132. South America Small Molecule Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 133. South America Small Molecule Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 134. South America Small Molecule Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 135. South America Small Molecule Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 136. South America Small Molecule Drug CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 137. South America Small Molecule Drug CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Middle East & Africa Small Molecule Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 139. Middle East & Africa Small Molecule Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 140. Middle East & Africa Small Molecule Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 141. Middle East & Africa Small Molecule Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 142. Middle East & Africa Small Molecule Drug CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 143. Middle East & Africa Small Molecule Drug CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 144. Small Molecule Drug CDMO Raw Material
Table 145. Key Suppliers of Small Molecule Drug CDMO Raw Materials
LIST OF FIGURES
Figure 1. Small Molecule Drug CDMO Picture
Figure 2. Global Small Molecule Drug CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Small Molecule Drug CDMO Consumption Value Market Share by Type in 2022
Figure 4. FDF CDMO
Figure 5. Packaging CDMO
Figure 6. Clinical CDMO
Figure 7. Global Small Molecule Drug CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Small Molecule Drug CDMO Consumption Value Market Share by Application in 2022
Figure 9. Pharmaceutical Company Picture
Figure 10. Biotechnology Company Picture
Figure 11. Other Picture
Figure 12. Global Small Molecule Drug CDMO Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Small Molecule Drug CDMO Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Small Molecule Drug CDMO Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Small Molecule Drug CDMO Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Small Molecule Drug CDMO Consumption Value Market Share by Region in 2022
Figure 17. North America Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Small Molecule Drug CDMO Revenue Share by Players in 2022
Figure 23. Small Molecule Drug CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Small Molecule Drug CDMO Market Share in 2022
Figure 25. Global Top 6 Players Small Molecule Drug CDMO Market Share in 2022
Figure 26. Global Small Molecule Drug CDMO Consumption Value Share by Type (2018-2023)
Figure 27. Global Small Molecule Drug CDMO Market Share Forecast by Type (2024-2029)
Figure 28. Global Small Molecule Drug CDMO Consumption Value Share by Application (2018-2023)
Figure 29. Global Small Molecule Drug CDMO Market Share Forecast by Application (2024-2029)
Figure 30. North America Small Molecule Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Small Molecule Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Small Molecule Drug CDMO Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Small Molecule Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Small Molecule Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Small Molecule Drug CDMO Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 40. France Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Small Molecule Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Small Molecule Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Small Molecule Drug CDMO Consumption Value Market Share by Region (2018-2029)
Figure 47. China Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 50. India Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Small Molecule Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Small Molecule Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Small Molecule Drug CDMO Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Small Molecule Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Small Molecule Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Small Molecule Drug CDMO Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 64. Small Molecule Drug CDMO Market Drivers
Figure 65. Small Molecule Drug CDMO Market Restraints
Figure 66. Small Molecule Drug CDMO Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Small Molecule Drug CDMO in 2022
Figure 69. Manufacturing Process Analysis of Small Molecule Drug CDMO
Figure 70. Small Molecule Drug CDMO Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Small Molecule Drug CDMO Picture
Figure 2. Global Small Molecule Drug CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Small Molecule Drug CDMO Consumption Value Market Share by Type in 2022
Figure 4. FDF CDMO
Figure 5. Packaging CDMO
Figure 6. Clinical CDMO
Figure 7. Global Small Molecule Drug CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Small Molecule Drug CDMO Consumption Value Market Share by Application in 2022
Figure 9. Pharmaceutical Company Picture
Figure 10. Biotechnology Company Picture
Figure 11. Other Picture
Figure 12. Global Small Molecule Drug CDMO Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Small Molecule Drug CDMO Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Small Molecule Drug CDMO Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Small Molecule Drug CDMO Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Small Molecule Drug CDMO Consumption Value Market Share by Region in 2022
Figure 17. North America Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Small Molecule Drug CDMO Revenue Share by Players in 2022
Figure 23. Small Molecule Drug CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Small Molecule Drug CDMO Market Share in 2022
Figure 25. Global Top 6 Players Small Molecule Drug CDMO Market Share in 2022
Figure 26. Global Small Molecule Drug CDMO Consumption Value Share by Type (2018-2023)
Figure 27. Global Small Molecule Drug CDMO Market Share Forecast by Type (2024-2029)
Figure 28. Global Small Molecule Drug CDMO Consumption Value Share by Application (2018-2023)
Figure 29. Global Small Molecule Drug CDMO Market Share Forecast by Application (2024-2029)
Figure 30. North America Small Molecule Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Small Molecule Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Small Molecule Drug CDMO Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Small Molecule Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Small Molecule Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Small Molecule Drug CDMO Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 40. France Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Small Molecule Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Small Molecule Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Small Molecule Drug CDMO Consumption Value Market Share by Region (2018-2029)
Figure 47. China Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 50. India Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Small Molecule Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Small Molecule Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Small Molecule Drug CDMO Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Small Molecule Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Small Molecule Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Small Molecule Drug CDMO Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 64. Small Molecule Drug CDMO Market Drivers
Figure 65. Small Molecule Drug CDMO Market Restraints
Figure 66. Small Molecule Drug CDMO Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Small Molecule Drug CDMO in 2022
Figure 69. Manufacturing Process Analysis of Small Molecule Drug CDMO
Figure 70. Small Molecule Drug CDMO Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
